Targeting SALL4 by entinostat in lung cancer

10.18632/oncotarget.12251

Saved in:
Bibliographic Details
Main Authors: Yong, K.J, Li, A, Ou, W.-B, Hong, C.K.Y, Zhao, W, Wang, F, Tatetsu, H, Yan, B, Qi, L, Fletcher, J.A, Yang, H, Soo, R, Tenen, D.G, Chai, L
Other Authors: MEDICINE
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/174105
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-174105
record_format dspace
spelling sg-nus-scholar.10635-1741052024-11-15T08:50:47Z Targeting SALL4 by entinostat in lung cancer Yong, K.J Li, A Ou, W.-B Hong, C.K.Y Zhao, W Wang, F Tatetsu, H Yan, B Qi, L Fletcher, J.A Yang, H Soo, R Tenen, D.G Chai, L MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE BIOCHEMISTRY entinostat epidermal growth factor receptor SALL4 protein somatomedin C receptor tumor protein unclassified drug antineoplastic agent benzamide derivative entinostat histone deacetylase inhibitor pyridine derivative SALL4 protein, human small interfering RNA transcription factor adult Article cancer growth cancer survival controlled study disease activity drug effect drug mechanism drug targeting female human lung cancer lung carcinogenesis major clinical study male molecular pathology protein determination protein expression protein function RNA interference signal transduction survival rate animal antagonists and inhibitors cell survival disease model drug screening gene expression genetics lung tumor mouse tumor cell line Animals Antineoplastic Agents Benzamides Cell Line, Tumor Cell Survival Disease Models, Animal Gene Expression Histone Deacetylase Inhibitors Humans Lung Neoplasms Mice Pyridines RNA Interference RNA, Small Interfering Transcription Factors Xenograft Model Antitumor Assays 10.18632/oncotarget.12251 Oncotarget 7 46 75425-75440 2020-09-03T10:30:53Z 2020-09-03T10:30:53Z 2016 Article Yong, K.J, Li, A, Ou, W.-B, Hong, C.K.Y, Zhao, W, Wang, F, Tatetsu, H, Yan, B, Qi, L, Fletcher, J.A, Yang, H, Soo, R, Tenen, D.G, Chai, L (2016). Targeting SALL4 by entinostat in lung cancer. Oncotarget 7 (46) : 75425-75440. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.12251 19492553 https://scholarbank.nus.edu.sg/handle/10635/174105 Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic entinostat
epidermal growth factor receptor
SALL4 protein
somatomedin C receptor
tumor protein
unclassified drug
antineoplastic agent
benzamide derivative
entinostat
histone deacetylase inhibitor
pyridine derivative
SALL4 protein, human
small interfering RNA
transcription factor
adult
Article
cancer growth
cancer survival
controlled study
disease activity
drug effect
drug mechanism
drug targeting
female
human
lung cancer
lung carcinogenesis
major clinical study
male
molecular pathology
protein determination
protein expression
protein function
RNA interference
signal transduction
survival rate
animal
antagonists and inhibitors
cell survival
disease model
drug screening
gene expression
genetics
lung tumor
mouse
tumor cell line
Animals
Antineoplastic Agents
Benzamides
Cell Line, Tumor
Cell Survival
Disease Models, Animal
Gene Expression
Histone Deacetylase Inhibitors
Humans
Lung Neoplasms
Mice
Pyridines
RNA Interference
RNA, Small Interfering
Transcription Factors
Xenograft Model Antitumor Assays
spellingShingle entinostat
epidermal growth factor receptor
SALL4 protein
somatomedin C receptor
tumor protein
unclassified drug
antineoplastic agent
benzamide derivative
entinostat
histone deacetylase inhibitor
pyridine derivative
SALL4 protein, human
small interfering RNA
transcription factor
adult
Article
cancer growth
cancer survival
controlled study
disease activity
drug effect
drug mechanism
drug targeting
female
human
lung cancer
lung carcinogenesis
major clinical study
male
molecular pathology
protein determination
protein expression
protein function
RNA interference
signal transduction
survival rate
animal
antagonists and inhibitors
cell survival
disease model
drug screening
gene expression
genetics
lung tumor
mouse
tumor cell line
Animals
Antineoplastic Agents
Benzamides
Cell Line, Tumor
Cell Survival
Disease Models, Animal
Gene Expression
Histone Deacetylase Inhibitors
Humans
Lung Neoplasms
Mice
Pyridines
RNA Interference
RNA, Small Interfering
Transcription Factors
Xenograft Model Antitumor Assays
Yong, K.J
Li, A
Ou, W.-B
Hong, C.K.Y
Zhao, W
Wang, F
Tatetsu, H
Yan, B
Qi, L
Fletcher, J.A
Yang, H
Soo, R
Tenen, D.G
Chai, L
Targeting SALL4 by entinostat in lung cancer
description 10.18632/oncotarget.12251
author2 MEDICINE
author_facet MEDICINE
Yong, K.J
Li, A
Ou, W.-B
Hong, C.K.Y
Zhao, W
Wang, F
Tatetsu, H
Yan, B
Qi, L
Fletcher, J.A
Yang, H
Soo, R
Tenen, D.G
Chai, L
format Article
author Yong, K.J
Li, A
Ou, W.-B
Hong, C.K.Y
Zhao, W
Wang, F
Tatetsu, H
Yan, B
Qi, L
Fletcher, J.A
Yang, H
Soo, R
Tenen, D.G
Chai, L
author_sort Yong, K.J
title Targeting SALL4 by entinostat in lung cancer
title_short Targeting SALL4 by entinostat in lung cancer
title_full Targeting SALL4 by entinostat in lung cancer
title_fullStr Targeting SALL4 by entinostat in lung cancer
title_full_unstemmed Targeting SALL4 by entinostat in lung cancer
title_sort targeting sall4 by entinostat in lung cancer
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/174105
_version_ 1821230858830348288